Summary
An association between arterial blood pressure and blood viscosity has been suggested in healthy and in diabetic subjects, and that the hemorheological pattern may be influenced by blood lipid alterations. In diabetic patients a relationship between arterial hypertension and blood lipid changes may therefore be suggested. This study concerns 19 type II diabetics with hyperlipidemia (triglycerides=3.2±1 mmol/l; total cholesterol=6.1±1.2 mmol/l; HDL-cholesterol=0.92±0.27 mmol/l; VLDL=29±5%) (group A), and 19 normolipidemic type II diabetics (triglycerides=1.15±0.5 mmol/l; total cholesterol=5.1±1 mmol/l; HDL-cholesterol =1.25±0.38 mmol/l; VLDL=20±5%) (group B). No differences concerning age, body weight, duration of diabetes and glycemic control were found in hyperlipidemic compared to normolipidemic diabetics. On the contrary, higher systolic and diastolic blood pressure levels were demonstrated in group A (167±14 mmHg and 101±5.2 mmHg, respectively) than in group B (144±15 mmHg, p<0.001 and 87±6.9 mmHg, p<0.001, respectively). An increase of plasma apolipoprotein B level (163±27 mg/dlvs 102±21 mg/dl, p<0.001), of plasma viscosity (1.81±0.08 mPasvs 1.51±0.07 mPas, p<0.001) and of blood viscosity (5.37±0.33 mPasvs 5.07±0.04 mPas, p<0.01, at shear-rate of 90 s−1; 18.4±1 mPasvs 14.1±0.9 mPas, p<0.001 at shear-rate of 2.25 s−1) was found in group A, compared to group B. Moreover several positive correlations (p<0.001) between apolipoprotein B level, plasma and blood viscosity were demonstrated in the hyperlipidemic diabetic patients. These findings suggest that blood changes in diabetes might be involved in the occurrence of blood pressure alterations.
Similar content being viewed by others
References
Albrink M. J., Lavietes, P. H., Man E. B.: Vascular disease and serum lipids in diabetes mellitus. Observations over thirty years (1931–1961)—Ann. intern. Med.58, 305 1963.
Allein C. C., Poon L. S., Chan C. S. G., Richmond W., Fu P. C.: Enzymatic determination of total serum cholesterol—Clin. Chem.,20, 470, 1974.
Barnes A. J., Locke P., Scudder P. R., Dormandy T. L., Dormandy J. A., Slack J.: Is hyperviscosity a treatable component of diabetic microcirculatory disease?—Lancetii, 789, 1977.
Bodansky H. J., Cudworth A. G., Drury P. L., Kohner E. M.: Risk factors associated with severe proliferative retinopathy in insulin-dependent diabetes mellitus—Diabetes Care5, 97, 1982.
Bucolo G., David H.: Quantitative determination of serum triglycerides by the use of enzymes—Clin. Chem.19, 476, 1973.
Carandente O., Colombo R., Girardi A. M., Margonato A., Pozza G.: Role of red cell sorbitol as determinant of reduced erythrocyte filtrability in insulin-dependent diabetics— Acta diabetol. lat.19, 359, 1982.
Chien S.: Present state of blood rheology. In:Messmer K., Schmid-Schönbein H. (Eds): Hemodilution theoretical basis and clinical application. Karger Basel, 1972; p. 110.
Chien S.: Blood rheology in hypertension and cardiovascular disease—Cardiovasc. Med.2, 356, 1977.
Chien S., Usami S., Dellenback R. J., Gregersen M. I.: Shear-dependent interaction of plasma proteins with erythrocytes in blood rheology—Amer. J. Physiol.219, 143, 1970.
Christlieb A. R.: Diabetes and hypertensive vascular disease. Mechanisms and treatment— Amer. J. Cardiol.32, 592 1973.
Christlieb A. R., Warram J. H., Królewski A. S., Busick E. J., Ganda O. P., Asmal A. C., Soeldner J. S., Bradley R. F.: Hypertension: the major risk factor in juvenile-onset insulin dependent diabetics—Diabetes30 (Suppl. 2), 90, 1981.
Drury P. L.: Diabetes and arterial hypertension—Diabetologia24, 1, 1983.
Dupont P. A., Sirs J. A.: The relationship of plasma fibrinogen, erythrocyte flexibility and blood viscosity—Thromb. Haemostas.38, 660 1977.
Eckel R. H., Mc Lean E., Albers J. J., Cheung, M. C., Bierman E. L.: Plasma lipids and microangiopathy in insulin-dependent diabetes mellitus—Diabetes Care4, 447, 1981.
Knowler W. C., Bennett P. H., Ballintine E. J.: Increased incidence of retinopathy in diabetics with elevated blood pressure—New Engl. J. Med.302 645, 1980.
Laurell C.: Quantitative estimation of protein by electrophoresis in agarose gel containing antibodies—Analyt. Biochem.15, 45, 1966.
Leonhardt H., Arntz H-H.: Blutviskosität und Erythrozytenflexibilität bei primären Hyperlipoproteinämien—Klin. Wschr56, 271, 1978.
Letcher R. L., Chien S., Pickering T. G., Sealey J. E., Laragh J. H.: Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects. Role of fibrinogen and concentration—Amer. J. Med.70, 1195, 1981.
Mc Millan D. E.: Plasma protein changes, blood viscosity and diabetic microangiopathy— Diabetes25 (Suppl. 2), 858, 1976.
Mc Millan D. E.: Physical factors important in the development of atherosclerosis in diabetes—Diabetes30 (Suppl. 2), 97, 1981.
Noble R. P., Hatch F. F., Mazzimas J. A., Lindgren F. T., Jensen L. C., Adamson G. L.: Comparison of lipoprotein analysis by agarose gel and paper electrophoresis with analytical ultracentrifugation—Lipids4, 55, 1969.
Parving H. H., Andersen A. R., Smidt U. M., Svendsen P. Aa.: Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy—Lanceti, 1175, 1983.
Parving H. H., Jensen H. A., Mogensen C. E., Evrin, P. E.: Increased albumin excretion rate in benign essential hypertension—Lanceti, 1190 1974.
Patti A. L., Solerte, S. B., Fedele P., Fioravanti M., Melzi D'Eril G. V., Gorrini M., Ferrari E.: Increased apolipoprotein B levels and blood hyperviscosity in type 2 (non-insulin-dependent) diabetic patients: role in the pathogenesis of arterial hypertension—Diabetologia29, 581 A, 1986; abstract # 395.
Pell S., D'Alonzo, C. A.: Some aspects of hypertension in diabetes mellitus—J. Amer. med. Ass.202, 104, 1967.
Schmid-Schönbein H., Volger E.: Red-cell aggregation and red-cell deformability in diabetes— Diabetes25 (Suppl. 2), 897, 1976.
Scholz P. M., Karis J. H., Gump F. E., Kinney J. M., Chien S.: Correlation of blood rheology with vascular resistance in critically ill patients—J. appl. Physiol.,39, 1008, 1975.
Steiner G.: Diabetes and atherosclerosis: an overview—Diabetes30 (Suppl. 2), 1, 1981.
Solerte S. B., Adamo S., Viola C., Carnevale Schianca G. P., Crippa A., Ferrari E.: Acute phase protein reactants pattern and α2-macroglobulin in diabetes mellitus. Pathophysiological aspects in diabetic microangiopathy—La Ricerca Clin. Lab.14 575, 1984.
Solerte S. B., Adamo S., Viola C., Zambianchi E., Ferrari E.: Pentossifillina ed ipertensione arteriosa nel diabete mellito: risultati a lungo termine in gruppi randomizzati. In:Pozza, G., Carandente O. (Eds): Emoreologia in laboratorio ed in clinica—La Ricerca Clin. Lab.15 (Suppl. 1), 515, 1985.
Solerte S. B., Ferrari E.: Arterial hypertension and haemorheological abnormalities in diabetes mellitus—Clin. Hemorheol.5, 699, 1985.
Solerte S. B., Piovella F., Viola C., Carnevale Schianca, G. P., Gamba G., Fioravanti M., Ferrari E.: Plasma fibronectin, von Willebrand factor antigen, and blood rheology. Association with diabetic microvascular disease—Acta diabetol. lat.22, 239, 1985.
Solerte S. B., Viola C., Adamo S., Dalzano M., Carnevale Schianca, G.P., Ferrari E.: Ipertensione arteriosa, iperviscosità e proteinuria nel diabete mellito insulino-dipendente di lunga durata. In:Pozza, G., Carandente O. (Eds.): Emoreologia in laboratorio ed in clinica— La Ricerca Clin. Lab.15 (Suppl. 1), 389, 1985.
Solerte S. B., Viola C., Bozzetti A., Adamo S., Di Santi M., Fioravanti M., Ferrari E.: Blood hyperviscosity, arterial hypertension and microangiopathic complications in non-insulin-dependent, (type 2) diabetes mellitus—G. ital. Diabetol.5 373, 1985.
Warnick G. R., Albers J. J.: Comprehensive evaluation of the heparin manganese precipitation procedure for the estimation of high density lipoprotein cholesterol.—J. Lipid Res.19, 65, 1978.
Wells R. E., Denton R., Merrill E. W.: Measurement of viscosity of biologic fluids by a cone plate viscometer—J. Lab. clin. Med.57, 646, 1961.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Solerte, S.B., Fioravanti, M., Patti, A.L. et al. Increased plasma apolipoprotein B levels and blood hyperviscosity in non-insulin-dependent diabetic patients: Role in the occurrence of arterial hypertension. Acta diabet. lat 24, 341–349 (1987). https://doi.org/10.1007/BF02742967
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02742967